{"protocolSection":{"identificationModule":{"nctId":"NCT00132470","orgStudyIdInfo":{"id":"AX200_P2A_1"},"organization":{"fullName":"Axaron Bioscience AG","class":"INDUSTRY"},"briefTitle":"Treatment With AX200 for Acute Ischemic Stroke","officialTitle":"AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2007-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2004-12"},"completionDateStruct":{"date":"2007-03"},"studyFirstSubmitDate":"2005-08-18","studyFirstSubmitQcDate":"2005-08-18","studyFirstPostDateStruct":{"date":"2005-08-22","type":"ESTIMATED"},"lastUpdateSubmitDate":"2007-07-23","lastUpdatePostDateStruct":{"date":"2007-07-25","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"Axaron Bioscience AG","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The AXIS study is a randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to investigate treatment with AX200 (granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke. The primary objective of the present phase IIa study is to assess the safety and tolerability of AX200 compared to placebo in subjects suffering from acute stroke. The secondary objective is to assess the effect of AX200 on subject outcome in comparison to placebo."},"conditionsModule":{"conditions":["Cerebral Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE"}},"enrollmentInfo":{"count":42}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"AX200 (G-CSF)"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety"}],"secondaryOutcomes":[{"measure":"Neurological outcome"},{"measure":"ischemic lesion growth"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Stroke onset within 12 hours prior to start of study agent administration\n* Ischemic stroke in the middle cerebral artery (MCA) territory confirmed by magnetic resonance imaging (MRI)\n\nExclusion Criteria:\n\n* Time interval since stroke onset impossible to determine\n* Carotid T-occlusion (magnetic resonance angiography \\[MRA\\])\n* Subarachnoid hemorrhages\n* Several safety parameters","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Wolf-R체diger Sch채bitz, MD","affiliation":"Universit채t M체nster","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Neurology University of Heidelberg","city":"Heidelberg","zip":"69120","country":"Germany","geoPoint":{"lat":49.40768,"lon":8.69079}},{"facility":"Neurology University of Muenster","city":"Muenster","zip":"48149","country":"Germany","geoPoint":{"lat":51.96236,"lon":7.62571}}]},"referencesModule":{"references":[{"pmid":"16007267","type":"BACKGROUND","citation":"Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005 Aug;115(8):2083-98. doi: 10.1172/JCI23559. Epub 2005 Jul 7."},{"pmid":"20947859","type":"DERIVED","citation":"Schabitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke. 2010 Nov;41(11):2545-51. doi: 10.1161/STROKEAHA.110.579508. Epub 2010 Oct 14."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}